scholarly journals Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysis

2020 ◽  
Vol 18 (9) ◽  
pp. 2296-2307 ◽  
Author(s):  
Victoria Speed ◽  
Bruce Green ◽  
Lara N. Roberts ◽  
Sarah Woolcombe ◽  
John Bartoli‐Abdou ◽  
...  
Keyword(s):  
Population Pharmacokinetic Analysis ◽  
Fixed Dose ◽  
Pharmacokinetic Analysis ◽  
Population Pharmacokinetic

Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysis ‐ Reply to Jacobs & Ryan comment

2021 ◽  
Vol 19 (3) ◽  
pp. 872-873
Author(s):  
Victoria Speed ◽  
Lara N. Roberts ◽  
Roopen Arya ◽  
Jignesh P. Patel
Keyword(s):  
Population Pharmacokinetic Analysis ◽  
Fixed Dose ◽  
Pharmacokinetic Analysis ◽  
Population Pharmacokinetic

Phase I dose-escalation study and population pharmacokinetic analysis of fixed dose rate gemcitabine plus carboplatin as second-line therapy in patients with ovarian cancer

2013 ◽  
Vol 130 (3) ◽  
pp. 511-517 ◽  
Author(s):  
Suzanne Leijen ◽  
Stephan A. Veltkamp ◽  
Alwin D.R. Huitema ◽  
E. van Werkhoven ◽  
Jos H. Beijnen ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Population Pharmacokinetic Analysis ◽  
Fixed Dose ◽  
Pharmacokinetic Analysis ◽  
Population Pharmacokinetic ◽  
Second Line ◽  
Second Line Therapy ◽  
Dose Escalation Study ◽  
Line Therapy ◽  
Fixed Dose Rate

scholarly journals Fixed Dose of Cemiplimab in Patients with Advanced Malignancies Based on Population Pharmacokinetic Analysis

2021 ◽  
Author(s):  
Anne J. Paccaly ◽  
Michael R. Migden ◽  
Kyriakos P. Papadopoulos ◽  
Feng Yang ◽  
John D. Davis ◽  
...  
Keyword(s):  
Population Pharmacokinetic Analysis ◽  
Fixed Dose ◽  
Pharmacokinetic Analysis ◽  
Population Pharmacokinetic ◽  
Advanced Malignancies
Sign in / Sign up

Export Citation Format

Share Document